Back to Search Start Over

Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection

Authors :
Vanina Boué
Carmen Lía Murall
Nathalie Jacobs
Claire Bernat
Massilva Rahmoun
Soraya Groc
Marine Bonneau
Jacques Reynes
Samuel Alizon
Christophe Hirtz
Christelle Graf
Christian Selinger
Sophie Grasset
Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC)
Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Institut de Génomique Fonctionnelle (IGF)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI)
Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Université de Liège
Centre interdisciplinaire de recherche en biologie (CIRB)
Labex MemoLife
École normale supérieure - Paris (ENS-PSL)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris)
Université Paris sciences et lettres (PSL)-École normale supérieure - Paris (ENS-PSL)
Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
European Project: 648963,H2020,ERC-2014-CoG,EVOLPROOF(2015)
Génétique et évolution des maladies infectieuses (GEMI)
Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI)
Alizon, Samuel
Are HPV vaccines ‘evolution-proof’? Multilevel evolutionary ecology of human oncoviruses - EVOLPROOF - - H20202015-09-01 - 2020-08-31 - 648963 - VALID
Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Source :
Immunologic Research, Immunologic Research, 2021, 69 (3), pp.255-263. ⟨10.1007/s12026-021-09196-2⟩, Immunologic Research, Humana Press, 2021, 69 (3), pp.255-263. ⟨10.1007/s12026-021-09196-2⟩
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

Human papillomaviruses (HPVs) are the most oncogenic viruses known to human, causing nearly all cervical cancers worldwide. Highly prevalent in young, sexually active women, most HPV infections are cleared within 3 years, and only a minority of those infections persist and lead to cancer later in life. To better characterize the immuno-modulatory impact of early HPV infection and more generally perturbations of the cervicovaginal milieu, we measured changes in a panel of 20 cytokines, known as highly dynamic effector molecules implicated in cell signaling. We analyzed 92 cervicovaginal samples collected from young, sexually active women who were tested for or diagnosed with HPV, chlamydia, and bacterial vaginosis. Also, symptoms associated with genital inflammation and infection were collected through self-reporting.Following a parsimonious multi-factor modeling approach, our statistical analyses revealed that increased IL-1Alpha and IL-12/IL-23p40 concentrations were associated with HPV infection. Cytokine network analysis further highlighted the role of IL-1Alpha and macrophage inflammatory proteins (MIP-3Alpha) in HPV-associated immuno-modulation.

Subjects

Subjects :
0301 basic medicine
Allergy
Cervix Uteri
Alphapapillomavirus
[SDV.BID.SPT]Life Sciences [q-bio]/Biodiversity/Systematics, Phylogenetics and taxonomy
0302 clinical medicine
Mucosal immunity
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Interleukin-1alpha
Medicine
Longitudinal Studies
Macrophage inflammatory protein
0303 health sciences
Chlamydia
Interleukin-12 Subunit p40
[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]
HPV infection
virus diseases
[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]
female genital diseases and pregnancy complications
3. Good health
Cytokine response
[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology
030220 oncology & carcinogenesis
[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Vagina
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Cytokines
Female
Bacterial vaginosis
medicine.symptom
Oncovirus
Adult
Adolescent
Immunology
Natural history
Inflammation
[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
Young Adult
03 medical and health sciences
Sexually active
[SDV.EE.ECO]Life Sciences [q-bio]/Ecology, environment/Ecosystems
Humans
Sex organ
030304 developmental biology
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health
030203 arthritis & rheumatology
[SDV.GEN.GPO]Life Sciences [q-bio]/Genetics/Populations and Evolution [q-bio.PE]
business.industry
Macrophages
Papillomavirus Infections
Cancer
Human Papillomavirus
medicine.disease
[INFO.INFO-MO]Computer Science [cs]/Modeling and Simulation
[SDV.MHEP.GEO] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
030104 developmental biology
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
[SDE.BE]Environmental Sciences/Biodiversity and Ecology
business
[SDV.EE.IEO]Life Sciences [q-bio]/Ecology, environment/Symbiosis

Details

Language :
English
ISSN :
0257277X
Database :
OpenAIRE
Journal :
Immunologic Research, Immunologic Research, 2021, 69 (3), pp.255-263. ⟨10.1007/s12026-021-09196-2⟩, Immunologic Research, Humana Press, 2021, 69 (3), pp.255-263. ⟨10.1007/s12026-021-09196-2⟩
Accession number :
edsair.doi.dedup.....f44f5b4d7fa8b2abe4c2b68cabd8a6cd